Current location - Training Enrollment Network - Books and materials - Selected proposals
Selected proposals
Edit comments/notes

Ethnic medicine (hereinafter referred to as "ethnic medicine") is a unique and indispensable part of China's medical culture with a long history. Ethnic medicine benefits the people with its distinctive diagnosis and treatment characteristics and plays an important role in improving people's health. In recent years, the development of ethnic medicine has made great progress, but there are still some problems in protection, inheritance and innovative application.

In this regard, the Central Committee of the Agricultural Workers' Party put forward a proposal on strengthening support for the development of ethnic medicine, and suggested supporting and guiding provinces and cities to declare national drug standards; Support the establishment of ethnic medicine research institutions and strengthen the scientific research strength of ethnic medicine; Promote the research and development of new drugs for ethnic medicine; Support ethnic doctors to practice medicine legally.

question

First, scientific research, protection and development are not strong enough.

Taking Yunnan Province as an example, the overall development and benefits of the industry need to be improved. For example, the scientific research and infrastructure construction of Hani medicine are relatively backward, and a special national medicine research institution has not yet been established. The Lisu, Naxi, Lahu and other ethnic minorities endemic to Yunnan have no relevant medical research institutions, not only lack qualified researchers, but also have no special ethnic hospitals.

Dai medicine, one of the four major ethnic medicines in China, is only a scientific research institution of Xishuangbanna Institute of Ethnic Medicine (Zhoudai Hospital). Due to insufficient investment, its scientific research ability and status do not match completely, and even it is challenged by international Dai medicine in neighboring countries.

Traditional Chinese medicine medical institutions at all levels have not set up departments related to ethnic medicine, and the existing clinical medical experience and drug production cannot be deepened continuously, which leads to great challenges in the protection and inheritance of ethnic medicine.

Second, the drug standards are lagging behind.

Taking Yunnan Province as an example, most of the ethnic medicines in Yunnan Province have not formulated corresponding standards, even the relatively mature ethnic medicines such as Dai medicine, Yi medicine and Tibetan medicine are not perfect. At present, the country has established three national medicine standard fascicles: Tibetan medicine standard, Mongolian medicine standard and Uygur medicine standard, but the lack of Dai medicine standard fascicles has seriously restricted the development of Dai medicine.

Third, it is difficult to transform research results.

Some ethnic medicine preparations with definite clinical efficacy, safety, stability and controllable quality have a long detention time and low pass rate in application, registration and approval, which hinders the transformation of scientific research results of ethnic medicine to some extent.

Fourth, the types of national doctor qualification examination are not comprehensive enough.

At present, there are more than 20 categories of doctor qualification examinations in China, including Chinese medicine, ethnic medicine and integrated traditional Chinese and western medicine. Ethnic medicine also includes Mongolian medicine, Tibetan medicine, Uygur medicine and Dai medicine. Doctors from other ethnic groups will not take the exam for the time being, so doctors from other ethnic groups cannot obtain industry access qualification through normal examination channels and practice medicine legally.

suggestion

First, support and guide provinces and cities to declare Chinese medicine standards.

The relevant departments of the state support and guide all localities to focus on selecting a number of medicinal materials for standard improvement research on the basis of the existing standards of ethnic medicinal materials, so as to meet the requirements of the classic famous prescription that "the taste of traditional Chinese medicine and the medicinal materials involved need national drug standards" and strive to include more ethnic medicinal materials in the national drug standards.

Two, support the establishment of ethnic medicine research institutions, strengthen the research strength of ethnic medicine.

Support ethnic minority areas to explore the cooperation between the government and enterprises to establish Chinese medicine disease prevention and treatment centers and clinical research bases. Support Chinese medical institutions at all levels, set up ethnic medicine departments when conditions are ripe, and enhance the ability to use ethnic medicine to prevent and treat diseases. Support ethnic minority areas to take the lead in establishing ethnic medicine museums, show the history and inheritance of ethnic medicine to guests at home and abroad, carry forward the culture of ethnic medicine, and provide a platform for scientific research exchange and learning for ethnic medicine lovers.

Third, promote the research and development of new drugs for ethnic medicine.

Because of the long period of new drug research and development, high technology content and large capital investment, large domestic pharmaceutical enterprises should be encouraged and guided to become the main body of national new drug research and development, and the initiative and enthusiasm of national pharmaceutical enterprises to carry out new drug research and development activities should be enhanced.

The relevant ministries and commissions of the state are requested to seriously study and formulate policies for the evaluation and marketization of new ethnic medicines, further improve the policies for drug registration and approval, build a "green channel" mechanism for innovative drugs, shorten the approval time for the first-phase clinical application documents of new drugs, improve the approval procedures for the listing of innovative drugs, and speed up the progress of drug technical evaluation.

Four, support the legal practice of ethnic doctors.

In addition to the existing national medical doctor qualification examination, the relevant training and examination standards of other national doctors should be formulated and standardized as soon as possible, so that national doctors can obtain legal medical qualifications.

Suggested organizers: State Administration of Pharmaceutical Products and National Health and Wellness Committee.

(Please indicate: China Internet CPPCC Channel "Discussion Library" APP platform)

Note: The CPPCC channel of China Network is now soliciting proposals for filing the meeting of China People's Political Consultative Conference on 20 19. You can submit it by downloading the "Discussion Library" application or sending an email to lujj@china.org.cn. We look forward to your participation!

Recommended reading:

Selected proposals | Let the babies in the village also enjoy the treatment of "playing in the city"? Look at the selection of this proposal of Zhi Gong Dang Central Committee | Democratic Progressive Central Committee: Optimizing Subsidy Policy to Promote the Development of General Aviation Industry